SYNBIOTIC SENA O.N. overview

EQS-News: SYNBIOTIC SE / Key word(s): Statement/Product Launch Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin 13.03.2025 / 11:14 CET/CEST The issuer is solely responsible for the content of this announcement. Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin The European industrial hemp and cannabis company group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) will...

EQS-News: SYNBIOTIC SE / Key word(s): Mergers & Acquisitions/Strategic Company Decision SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 10.01.2025 / 11:44 CET/CEST The issuer is solely responsible for the content of this announcement. SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 The European industrial hemp and cannabis group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) is planning further strategically important...

EQS-News: SYNBIOTIC SE / Key word(s): Investment Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis 18.12.2024 / 13:06 CET/CEST The issuer is solely responsible for the content of this announcement. The European industrial hemp and cannabis group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) announced a strategic partnership with GOC NEXUS OPERATIONS GmbH on 13 December 2024. This collaboration marks a significant step in the further development and...

EQS-News: SYNBIOTIC SE / Key word(s): Mergers & Acquisitions SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry 25.11.2024 / 11:39 CET/CEST The issuer is solely responsible for the content of this announcement. The European hemp and cannabis group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) announces the integration of greensby with the acquisition of 50.2 % of the shares. This strategic move creates a unique platform that bundles all of the Group's...

EQS-News: SYNBIOTIC SE / Key word(s): Miscellaneous In full bloom: WEECO Pharma boosts SYNBIOTIC's sales 14.11.2024 / 13:30 CET/CEST The issuer is solely responsible for the content of this announcement. The acquisition of WEECO Pharma by the European hemp and cannabis group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) is proving to be a valuable deal in the truest sense of the word. WEECO Pharma is well above the previously planned revenue target for 2024, at EUR 6.75 million as of the end of...

EQS-News: SYNBIOTIC SE / Key word(s): AGM/EGM Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval 27.09.2024 / 11:19 CET/CEST The issuer is solely responsible for the content of this announcement. The Annual General Meeting of SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) has confirmed the strategic growth course of the European industrial hemp and cannabis company group with an overwhelming majority. At the virtual Annual...

EQS-News: SYNBIOTIC SE / Key word(s): AGM/EGM/Development of Sales SYNBIOTIC Annual General Meeting on 20.09.2024: Increasing sales drive growth 16.08.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. The Annual General Meeting of SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5), one of Europe's leading industrial hemp and cannabis companies, will take place on Friday, 20 September 2024 . In the run-up to the Annual General Meeting, Daniel Kruse, CEO of...

EQS-News: SYNBIOTIC SE / Key word(s): Miscellaneous Berlin, Prague, Berlin: SYNBIOTIC and CEO Daniel Kruse on roadshow 23.05.2024 / 10:31 CET/CEST The issuer is solely responsible for the content of this announcement. The leading European industrial hemp and cannabis group SYNBIOTIC is increasing its public presence. " We want to be even more visible and approachable in the professional world and for our investors ," explains Daniel Kruse, CEO of SYNBIOTIC. "The aim is to position the enormous...